About Cobra Biologics
Cobra Biologics is a company based in Keele (United Kingdom) founded in 1992 was acquired by Flerie in October 2021.. The company has 111 employees as of December 31, 2024. Cobra Biologics offers products and services including Plasmid DNA Manufacturing, Viral Vector Manufacturing, Cell Therapy Manufacturing, Viral Vector Packaging, and Custom Cloning. Cobra Biologics operates in a competitive market with competitors including Amyris, Inscripta, Pivot Bio, Ginkgo Bioworks and Syngenta, among others.
- Headquarter Keele, United Kingdom
- Employees 111 as on 31 Dec, 2024
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cobra Biologics Limited
- Date of Incorporation 29 Apr, 1992
- Jurisdiction KEELE, STAFFORDSHIRE
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cobra Biologics
Cobra Biologics offers a comprehensive portfolio of products and services, including Plasmid DNA Manufacturing, Viral Vector Manufacturing, Cell Therapy Manufacturing, Viral Vector Packaging, and Custom Cloning. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Produces plasmid DNA for advanced therapy applications.
Develops viral vectors for gene and cell therapies.
Provides manufacturing for cell-based therapeutic products.
Packages viral vectors for safe therapy delivery.
Offers custom cloning for genetic therapy research.
Unlock access to complete
Funding Insights of Cobra Biologics
- Total Funding Total Funding
- Total Rounds 3
- Last Round Last Round
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2018 | Amount | Grant - Cobra Biologics | Valuation |
investors |
|
| Jan, 2018 | Amount | Grant - Cobra Biologics | Valuation |
investors |
|
| Apr, 2015 | Amount | Grant - Cobra Biologics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Cobra Biologics
Cobra Biologics has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Gov.uk, Cognate Bioservices and Flerie. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Flerie is engaged in investing in biotech and pharmaceutical companies.
|
Founded Year | Domain | Location | |
|
Online government services and information are provided to users.
|
Founded Year | Domain | Location | |
|
Development and manufacturing services for cell-based therapies are provided.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cobra Biologics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Cobra Biologics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cobra Biologics Comparisons
Competitors of Cobra Biologics
Cobra Biologics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Amyris, Inscripta, Pivot Bio, Ginkgo Bioworks and Syngenta, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of renewable products for industrial solutions
|
|
| domain | founded_year | HQ Location |
Speech recognition solutions are provided by Inscripta for healthcare professionals.
|
|
| domain | founded_year | HQ Location |
Nitrogen-fixing microbes for corn crop nutrition are developed and applied.
|
|
| domain | founded_year | HQ Location |
Gene editing-based cultured ingredients are provided for agriculture.
|
|
| domain | founded_year | HQ Location |
Crop protection solutions and hybrid seeds are provided for farming.
|
|
| domain | founded_year | HQ Location |
Provider of integrated suite for advanced genetic design and manufacturing
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cobra Biologics
Frequently Asked Questions about Cobra Biologics
When was Cobra Biologics founded?
Cobra Biologics was founded in 1992 and raised its 1st funding round 23 years after it was founded.
Where is Cobra Biologics located?
Cobra Biologics is headquartered in Keele, United Kingdom. It is registered at Keele, England, United Kingdom.
How many employees does Cobra Biologics have?
As of Dec 31, 2024, the latest employee count at Cobra Biologics is 111.
What is the annual revenue of Cobra Biologics?
Annual revenue of Cobra Biologics is $33.57M as on Dec 25, 2021.
What does Cobra Biologics do?
Cobra Biologics provides contract development and manufacturing solutions to the global life sciences industry covering monoclonal antibodies, recombinant proteins, DNA, viruses, API, cell line derived products for clinical trials and others. Cobra has three GMP approved facilities in Sweden and UK. Cobras drug development services begin from cell line and process development and right until fill and finish and supply for investigational medicinal products and commercial production. The company also offers lyophilisation and fill-finish services for small molecules. Cobra offering includes protein characterization (including peptide mapping, disulphide bridge analysis etc.) bioassay development (cell-based and enzymatic bioassays to quantify the potency of biomolecules) and analytical services. Cobra has proprietary technologies such as Maximum Protein Expression (that uses Ubiquitous Chromatin Opening Elements (UCOEs) technology) to rapidly produce proteins and MAbs from mammalian cells, Automated Bioreactor (from TAP Biosystems) for microbial cell line development and process optimisation, A PEGylation platform through their partnership with QuiaPEG Pharmaceuticals, and an Antibiotic-free Maintenance System called ORT (Operator-Repressor Titration) for producing plasmid DNA without antibiotics, antibiotic resistance genes, with applications in DNA Vaccines, Gene therapy and recombinant protein production.
Who are the top competitors of Cobra Biologics?
What products or services does Cobra Biologics offer?
Cobra Biologics offers Plasmid DNA Manufacturing, Viral Vector Manufacturing, Cell Therapy Manufacturing, Viral Vector Packaging, and Custom Cloning.
Who are Cobra Biologics's investors?
Cobra Biologics has 3 investors. Key investors include Gov.uk, Cognate Bioservices, and Flerie.